96 related articles for article (PubMed ID: 9471369)
1. [Tumor markers in the diagnosis of thyroid cancer].
Slavnov VN; Markov VV; Kovalenko AE; Kovpan NA; Kvacheniuk AN
Lik Sprava; 1997; (4):31-4. PubMed ID: 9471369
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma.
Suzuki S; Furukawa H; Tsuchiya A
Thyroid; 1999 Sep; 9(9):921-5. PubMed ID: 10524571
[TBL] [Abstract][Full Text] [Related]
3. Serum ferritin in thyroid cancer.
Deshpande UR; Nadkarni GD; Samuel AM
Thyroid; 1993; 3(4):301-3. PubMed ID: 8118224
[TBL] [Abstract][Full Text] [Related]
4. Serum Immunoproteomics Combined With Pathological Reassessment of Surgical Specimens Identifies TCP-1ζ Autoantibody as a Potential Biomarker in Thyroid Neoplasia.
Belousov PV; Bogolyubova AV; Kim YS; Abrosimov AY; Kopylov AT; Tvardovskiy AA; Lanshchakov KV; Sazykin AY; Dvinskikh NY; Bobrovskaya YI; Selivanova LS; Shilov ES; Schwartz AM; Shebzukhov YV; Severskaia NV; Vanushko VE; Moshkovskii SA; Nedospasov SA; Kuprash DV
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1206-15. PubMed ID: 26196948
[TBL] [Abstract][Full Text] [Related]
5. Oncofoetal fibronectin--a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma.
Hesse E; Musholt PB; Potter E; Petrich T; Wehmeier M; von Wasielewski R; Lichtinghagen R; Musholt TJ
Br J Cancer; 2005 Sep; 93(5):565-70. PubMed ID: 16091757
[TBL] [Abstract][Full Text] [Related]
6. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
7. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
Zöphel K; Wunderlich G; Smith BR
Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
[TBL] [Abstract][Full Text] [Related]
8. Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer.
Fatourechi V; Hay ID; Javedan H; Wiseman GA; Mullan BP; Gorman CA
J Clin Endocrinol Metab; 2002 Apr; 87(4):1521-6. PubMed ID: 11932275
[TBL] [Abstract][Full Text] [Related]
9. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
10. [Role of blood and nucleic acid testing in diagnosis of thyroid carcinoma].
Takano T
Nihon Rinsho; 2007 Nov; 65(11):1991-5. PubMed ID: 18018560
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokeratins determination in differentiated thyroid carcinoma.
Appetecchia M; Meçule A; Ducci M; Palma L; Castelli M
J Exp Clin Cancer Res; 2001 Jun; 20(2):253-6. PubMed ID: 11484983
[TBL] [Abstract][Full Text] [Related]
12. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
[TBL] [Abstract][Full Text] [Related]
13. [The clinical usefulness of tumor markers in thyroid neoplastic pathology. Our experience].
Gerardi G; De Angelis P
Minerva Med; 1994 May; 85(5):237-40. PubMed ID: 8028752
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
15. [Use of BRAF V600E mutation in the differential diagnosis of follicular and papillary tumors of the thyroid and for the optimization of thearpy].
Semënov DIu; Boriskova ME; Zaraĭskiĭ MI; Saburova IIu; Pankova PA; Farafonova UV; Bykov MA
Vopr Onkol; 2012; 58(5):649-52. PubMed ID: 23600282
[TBL] [Abstract][Full Text] [Related]
16. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.
Tomoda C; Kushima R; Takeuti E; Mukaisho K; Hattori T; Kitano H
Thyroid; 2003 Mar; 13(3):291-5. PubMed ID: 12729479
[TBL] [Abstract][Full Text] [Related]
17. Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer.
Guarino E; Tarantini B; Pilli T; Checchi S; Brilli L; Ciuoli C; Di Cairano G; Mazzucato P; Pacini F
Thyroid; 2005 Sep; 15(9):1041-5. PubMed ID: 16187912
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcinoma.
Razfar A; Branstetter BF; Christopoulos A; Lebeau SO; Hodak SP; Heron DE; Escott EJ; Ferris RL
Arch Otolaryngol Head Neck Surg; 2010 Feb; 136(2):120-5. PubMed ID: 20157055
[TBL] [Abstract][Full Text] [Related]
19. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
20. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
